Carbetocin

Generic Name
Carbetocin
Brand Names
Duratocin
Drug Type
Small Molecule
Chemical Formula
C45H69N11O12S
CAS Number
37025-55-1
Unique Ingredient Identifier
88TWF8015Y
Background

Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.

Indication

Used to control postpartum hemorrhage and bleeding after giving birth.

Associated Conditions
Postpartum Haemorrhage (PPH), Uterine Atony
Associated Therapies
-

Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery

First Posted Date
2018-11-28
Last Posted Date
2018-11-28
Lead Sponsor
Al-Kindy College of Medicine
Target Recruit Count
300
Registration Number
NCT03755531
Locations
🇮🇶

Al Kindy College of Medicine/ University of Baghdad, Baghdad, Iraq

Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study

Phase 4
Completed
Conditions
Interventions
First Posted Date
2018-10-23
Last Posted Date
2021-05-14
Lead Sponsor
University of British Columbia
Target Recruit Count
50
Registration Number
NCT03716076
Locations
🇨🇦

BC Women's Hospital, Vancouver, British Columbia, Canada

Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section

First Posted Date
2018-10-18
Last Posted Date
2020-08-05
Lead Sponsor
Aswan University Hospital
Target Recruit Count
400
Registration Number
NCT03710317
Locations
🇪🇬

Aswan University, Aswan, Egypt

Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery

First Posted Date
2018-10-17
Last Posted Date
2020-08-05
Lead Sponsor
Aswan University Hospital
Target Recruit Count
360
Registration Number
NCT03708497
Locations
🇪🇬

AswanUH, Aswan, Egypt

🇪🇬

Aswan University, Aswan, Egypt

Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean

Phase 4
Completed
Conditions
Interventions
First Posted Date
2018-10-03
Last Posted Date
2020-01-03
Lead Sponsor
Cairo University
Target Recruit Count
1200
Registration Number
NCT03693599
Locations
🇪🇬

faculty of medicine Cairo university, Giza, Egypt

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-09-14
Last Posted Date
2019-06-07
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
30
Registration Number
NCT03672045
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections

Phase 4
Completed
Conditions
Interventions
First Posted Date
2018-08-29
Last Posted Date
2023-05-24
Lead Sponsor
University of Zurich
Target Recruit Count
550
Registration Number
NCT03651882
Locations
🇨🇭

University Hospital Zurich, Zürich, Switzerland

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage

First Posted Date
2018-07-06
Last Posted Date
2020-08-05
Lead Sponsor
Aswan University Hospital
Target Recruit Count
220
Registration Number
NCT03578263
Locations
🇪🇬

AswanUH, Aswan, Egypt

CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE

Phase 4
Completed
Conditions
Interventions
First Posted Date
2018-06-14
Last Posted Date
2019-10-11
Lead Sponsor
Cairo University
Target Recruit Count
150
Registration Number
NCT03556852
Locations
🇪🇬

Kasr Alainy medical school, Cairo, Egypt

Carbetocin vs. Oxytocin at Elective Cesarean Section

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2017-05-30
Last Posted Date
2021-03-03
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
278
Registration Number
NCT03168698
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

🇨🇦

McMaster University Medical Centre (MUMC), Hamilton, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath